A Study Evaluating the Efficacy and Safety of Sildenafil in Patients With Erectile Dysfunction Receiving Hemodialysis
Status:
Completed
Trial end date:
2005-04-01
Target enrollment:
Participant gender:
Summary
The study was done to evaluate the efficacy, safety, and tolerability of orally administered
sildenafil taken as needed about one hour before sexual activity after a 10-week period in
male outpatients with erectile dysfunction and severe renal failure who were on hemodialysis.
Phase:
Phase 4
Details
Lead Sponsor:
Pfizer Pfizer's Upjohn has merged with Mylan to form Viatris Inc.